1. Home
  2. XYF vs ALT Comparison

XYF vs ALT Comparison

Compare XYF & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYF
  • ALT
  • Stock Information
  • Founded
  • XYF 2014
  • ALT 1997
  • Country
  • XYF China
  • ALT United States
  • Employees
  • XYF N/A
  • ALT N/A
  • Industry
  • XYF Finance: Consumer Services
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • XYF Finance
  • ALT Health Care
  • Exchange
  • XYF Nasdaq
  • ALT Nasdaq
  • Market Cap
  • XYF 582.9M
  • ALT 472.3M
  • IPO Year
  • XYF 2018
  • ALT N/A
  • Fundamental
  • Price
  • XYF $17.14
  • ALT $7.03
  • Analyst Decision
  • XYF
  • ALT Strong Buy
  • Analyst Count
  • XYF 0
  • ALT 7
  • Target Price
  • XYF N/A
  • ALT $21.00
  • AVG Volume (30 Days)
  • XYF 356.6K
  • ALT 3.8M
  • Earning Date
  • XYF 05-19-2025
  • ALT 08-07-2025
  • Dividend Yield
  • XYF 1.45%
  • ALT N/A
  • EPS Growth
  • XYF 32.83
  • ALT N/A
  • EPS
  • XYF 4.76
  • ALT N/A
  • Revenue
  • XYF $909,710,294.00
  • ALT $20,000.00
  • Revenue This Year
  • XYF N/A
  • ALT N/A
  • Revenue Next Year
  • XYF N/A
  • ALT $1,557,547.90
  • P/E Ratio
  • XYF $3.61
  • ALT N/A
  • Revenue Growth
  • XYF 31.55
  • ALT N/A
  • 52 Week Low
  • XYF $3.78
  • ALT $3.55
  • 52 Week High
  • XYF $19.80
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • XYF 49.81
  • ALT 66.62
  • Support Level
  • XYF $16.56
  • ALT $6.61
  • Resistance Level
  • XYF $19.00
  • ALT $7.48
  • Average True Range (ATR)
  • XYF 1.14
  • ALT 0.53
  • MACD
  • XYF -0.36
  • ALT 0.10
  • Stochastic Oscillator
  • XYF 17.90
  • ALT 79.32

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: